Profiling cancer metabolism at the 'omic' level: a last resort or the next frontier?
A convincing example of the power of untargeted metabolomics to identify serum markers of non-small-cell lung cancer was recently published in the Journal of Clinical Oncology. Untargeted metabolomics provides data on a larger number of compounds, but the data are less quantitatively reliable. [...]...
Gespeichert in:
Veröffentlicht in: | Cancer & metabolism 2016-03, Vol.4 (1), p.2-2, Article 2 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A convincing example of the power of untargeted metabolomics to identify serum markers of non-small-cell lung cancer was recently published in the Journal of Clinical Oncology. Untargeted metabolomics provides data on a larger number of compounds, but the data are less quantitatively reliable. [...]if an investigator has a research question that can be answered with a targeted analysis, that is the recommended experiment. |
---|---|
ISSN: | 2049-3002 2049-3002 |
DOI: | 10.1186/s40170-016-0144-x |